Maquet Forms Response Team to Address Warning Letter

When Maquet Cardiovascular got a warning letter last month citing it for the way Boston Scientific handled a recall four years ago, it formed a special team, including external consultants, that met daily so it could resolve the issues as quickly as possible. Each team member was assigned specific duties with deadlines attached, Christian Keller, president and CEO, said, adding that the company has submitted the documentation requested by the FDA.
Device & Diagnostics Letter